AN2 Therapeutics, Inc. · CIK 1880438
AN2 Therapeutics, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
Mar 25, 2026
through Mar 25, 2026
through Mar 25, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $39,999,989
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $39,999,989
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Same reported sales compensation recipient
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Aviceda Therapeutics, Inc. · CIK 1824762
- Ikena Oncology, Inc. · CIK 1835579
- OmniAb, Inc. · CIK 1846253
- RAPT Therapeutics, Inc. · CIK 1673772
- Zai Lab Ltd · CIK 1704292
Form D filings (1)
-
0001880438-26-000001D · Mar 25, 2026 · PharmaceuticalsOffering: $39,999,989Sold: $39,999,989